Founded in 2012, INC Pharma is a 100% Turkish capital owned company that manufactures and markets drugs. INC Pharma develops its pharmaceutical products at well-qualified R&D Centers and manufactures its products at contract manufacturers with EU and Turkish-GMP certification in full compliance with local and international regulations. With a current portfolio consisting of hospital products, INC Pharma aims to extend its portfolio into a wider spectrum of products. In line with this aim, INC Pharma signs agreements with pharmaceutical companies to market their products in foreign markets. We have been enlarging our commercial activities and widening our geographical coverage by adding new local distributors to our family of business partners.
| Website | http://www.incpharma.com.tr/ |
| Revenue | $5.9 million |
| Employees | 19 (9 on RocketReach) |
| Founded | 2012 |
| Address | 3 34173 Merter-gungoren, Istanbul, Istanbul 34188, TR |
| Phone | +90 212 637 49 10 |
| Technologies |
JavaScript
,
HTML
,
Bootstrap
+7 more
(view full list)
|
| Industry | Pharmaceutical Manufacturing, Manufacturing General, Manufacturing |
| Keywords | Pharmaceutical, Pharmaceutical Products, Pharmaceutical Research, Drugs, Drug Manufacturing, Medicine Development, Drug Production, R&D Center, Prescription Drugs, Pharmacy, Drug Discovery, Contract Manufacturing, Healthcare, Eu Gmp, Generic Drugs, Clinical Trials, Health |
| Competitors | Roche, Pfizer, Bayer, AstraZeneca, Novartis, AbbVie, Johnson & Johnson, Sanofi, GSK, Merck AH +39 more (view full list) |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 32 Companies, NAICS Code 325 Companies |
Looking for a particular INC Pharmaceuticals employee's phone or email?
The INC Pharmaceuticals annual revenue was $5.9 million in 2026.
9 people are employed at INC Pharmaceuticals.
INC Pharmaceuticals is based in Istanbul, Istanbul.
The NAICS codes for INC Pharmaceuticals are [3254, 32541, 32, 325].
The SIC codes for INC Pharmaceuticals are [28, 283].